Țară: Regatul Unit
Limbă: engleză
Sursă: VMD (Veterinary Medicines Directorate)
Mepivacaine Hydrochloride
VetViva Richter GmbH
QN01BB03
Mepivacaine Hydrochloride
Solution for injection
POM-V - Prescription Only Medicine – Veterinarian
Horses
Neurological Agent local anaesthetic
Authorized
2017-11-15
Revised: January 2023 AN: 02966/2022 Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Mepivacaine Richter 20 mg/ml solution for injection for horses 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: ACTIVE SUBSTANCE: Mepivacaine hydrochloride 20 mg (equivalent to 17.4 mg Mepivacaine) For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for injection. Clear, colourless to slightly yellow solution 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Horse 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Mepivacaine is indicated for intra-articular and epidural anaesthesia in horses. 4.3 CONTRAINDICATIONS Do not use in cases of known hypersensitivity to local anaesthetics belonging to the amide group, or to any of the excipients. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals Aspirate prior to and during administration to avoid intra-vascular injection. Revised: January 2023 AN: 02966/2022 Page 2 of 5 The analgesic effect of mepivacaine, when used as part of a lameness investigation, begins to subside after 45-60 minutes. However, sufficient analgesia may persist to affect gait beyond two hours. Special precautions to be taken by the person administering the veterinary medicinal product to animals People with known hypersensitivity to mepivacaine or other local anaesthetics of the amide group should avoid contact with the veterinary medicinal product. This product may be an irritant to the skin and eyes. Avoid contact with the skin and eyes. Wash any splashes from skin and eyes immediately with plenty of water. Seek medical advice if irritation persists. Adverse effects on the foetus cannot be excluded. Pregnant women should avoid handling the product. Accidental self-injection may result in cardiorespiratory and/or CNS effects. Care should be taken to avoid accidental self-injection. In case of accidental self-injection seek medical advice immediately and show the Citiți documentul complet